Anti-HGFR / c-Met Reference Antibody (emibetuzumab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Rat, Cynomolgus |
Conjugation | Unconjugated |
Anti-HGFR / c-Met Reference Antibody (emibetuzumab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Rat, Cynomolgus |
Conjugation | Unconjugated |
Anti-LAG3 / CD223 Reference Antibody (relatlimab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Cynomolgus |
Conjugation | Unconjugated |
Anti-SIRPg / CD172g Reference Antibody (KWAR23)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Mouse, Macaque, Cynomolgus |
Conjugation | Unconjugated |
Anti-ANGPTL3 Reference Antibody (evinacumab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Mouse, Cynomolgus |
Conjugation | Unconjugated |
Anti-BTLA / CD272 Reference Antibody (icatolimab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Cynomolgus |
Conjugation | Unconjugated |
Anti-CSF1R / M-CSFR / CD115 Reference Antibody (cabiralizumab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Cynomolgus |
Conjugation | Unconjugated |
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (sintilimab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Cynomolgus |
Conjugation | Unconjugated |
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (camrelizumab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Cynomolgus |
Conjugation | Unconjugated |
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (spartalizumab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Cynomolgus |
Conjugation | Unconjugated |
Anti-OSMR Reference Antibody (vixarelimab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Cynomolgus |
Conjugation | Unconjugated |
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (serplulimab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Cynomolgus |
Conjugation | Unconjugated |
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (pembrolizumab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Cynomolgus |
Conjugation | Unconjugated |
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (cemiplimab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Cynomolgus |
Conjugation | Unconjugated |
Anti-FcRn (FCGRT & B2M) Reference Antibody (rozanolixizumab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Mouse, Cynomolgus |
Conjugation | Unconjugated |
Anti-IL-6 / IFNb2 Reference Antibody (olokizumab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Macaque, Cynomolgus |
Conjugation | Unconjugated |